We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

RNAC Cartesian Therapeutics Inc

0.0511 (6.97%)
Last Updated: 14:53:33
Delayed by 15 minutes


Draw Mode:

Volume 592,116
Bid Price 0.7682
Ask Price 0.7996
News -
Day High 0.8582


52 Week Range


Day Low 0.70
Company Name Stock Ticker Symbol Market Type
Cartesian Therapeutics Inc RNAC NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0511 6.97% 0.7839 14:53:33
Open Price Low Price High Price Close Price Prev Close
0.7261 0.70 0.8582 0.7328
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
1,927 592,116 $ 0.7480542 $ 442,935 - 0.6648 - 1.42
Last Trade Time Type Quantity Stock Price Currency
14:55:40 1 $ 0.7994 USD

Cartesian Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
117.96M 155.20M - 110.78M 35.38M 0.23 3.33
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Cartesian Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No RNAC Message Board. Create One! See More Posts on RNAC Message Board See More Message Board Posts

Historical RNAC Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.121.350.66480.93913251,988,255-0.3361-30.01%
1 Month0.80651.420.66481.031,403,143-0.0226-2.8%
3 Months0.80651.420.66481.031,403,143-0.0226-2.8%
6 Months0.80651.420.66481.031,403,143-0.0226-2.8%
1 Year0.80651.420.66481.031,403,143-0.0226-2.8%
3 Years0.80651.420.66481.031,403,143-0.0226-2.8%
5 Years0.80651.420.66481.031,403,143-0.0226-2.8%

Cartesian Therapeutics Description

Selecta Biosciences Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. Its product pipeline includes MMA-101, SEL-212 for Chronic Severe Gout, SEL-313 for Ornithine Transcarbamylase Deficiency (OTC), and others.

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 |